MedPath

EPIDIOLEX

EPIDIOLEX

Approved
DIN Number

02543079

Drug Class

Human

Market Date

Mar 28, 2024

Company
HC

JAZZ PHARMACEUTICALS RESEARCH UK LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02543079
AIG Number0165301001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX24 CANNABIDIOL
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

CANNABIDIOLActive
Strength: 100 MG / ML
Monograph: CANNABIDIOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.